RBFC
GILD icon

Roman Butler Fullerton & Co’s Gilead Sciences GILD Stock Holding History

Roman Butler Fullerton & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$303K Sell
2,308
-31
-1% -$4.08K 0.07% 236
2026
Q1 		$331K Buy
2,339
+31
+1% +$4.34K 0.09% 205
2025
Q4 		$303K Sell
2,308
-762
-25% -$92.6K 0.08% 223
2025
Q3 		$364K Sell
3,070
-2,594
-46% -$295K 0.1% 188
2025
Q2 		$658K Sell
5,664
-120
-2% -$12.8K 0.19% 125
2025
Q1 		$611K Buy
5,784
+2,654
+85% +$274K 0.24% 108
2024
Q4 		$298K Buy
+3,130
New +$282K 0.09% 179
2024
Q3 		– Sell
-3,445
Closed -$237K – 254
2024
Q2 		$237K Buy
3,445
+81
+2% +$5.41K 0.08% 210
2024
Q1 		$225K Sell
3,364
-735
-18% -$56.5K 0.08% 198
2023
Q4 		$326K Sell
4,099
-240
-6% -$18.7K 0.13% 164
2023
Q3 		$337K Sell
4,339
-20
-0.5% -$1.54K 0.16% 140
2023
Q2 		$344K Sell
4,359
-88
-2% -$7.02K 0.16% 145
2023
Q1 		$381K Sell
4,447
-96
-2% -$7.95K 0.19% 136
2022
Q4 		$388K Buy
4,543
+196
+5% +$15.5K 0.2% 133
2022
Q3 		$285K Sell
4,347
-95
-2% -$5.99K 0.18% 143
2022
Q2 		$278K Buy
4,442
+103
+2% +$6.38K 0.15% 153
2022
Q1 		$258K Sell
4,339
-762
-15% -$48.7K 0.12% 171
2021
Q4 		$370K Sell
5,101
-40
-0.8% -$2.75K 0.16% 135
2021
Q3 		$339K Sell
5,141
-41
-0.8% -$2.88K 0.16% 145
2021
Q2 		$357K Sell
5,182
-79
-2% -$5.28K 0.17% 134
2021
Q1 		$346K Sell
5,261
-41
-0.8% -$2.64K 0.17% 143
2020
Q4 		$309K Buy
5,302
+39
+0.7% +$2.35K 0.18% 128
2020
Q3 		$333K Sell
5,263
-158
-3% -$11K 0.22% 115
2020
Q2 		$417K Buy
+5,421
New +$415K 0.3% 103
2020
Q1 		– Sell
-8,221
Closed -$534K – 148
2019
Q4 		$534K Sell
8,221
-790
-9% -$51.4K 0.35% 91
2019
Q3 		$571K Sell
9,011
-377
-4% -$24.6K 0.39% 87
2019
Q2 		$634K Sell
9,388
-750
-7% -$49.3K 0.43% 83
2019
Q1 		$659K Sell
10,138
-1,013
-9% -$67.3K 0.46% 71
2018
Q4 		$759K Buy
+11,151
New +$779K 0.65% 54

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Roman Butler Fullerton & Co's GILD Position: Q2 2026 in Review

Roman Butler Fullerton & Co reduced its Gilead Sciences (GILD) stake by 1.3% in Q2 2026, selling an estimated $4.08K and leaving 2,308 shares worth $303K. The position accounts for 0.07% of the portfolio, ranked #236.

Roman Butler Fullerton & Co first reported a position in GILD in Q4 2018 and has held it in 29 quarters since. The position peaked at $759K in Q4 2018. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Roman Butler Fullerton & Co held 2,308 shares of Gilead Sciences worth $303K as of Q2 2026.
  • Roman Butler Fullerton & Co sold 31 Gilead Sciences shares in Q2 2026, an estimated $4.08K.
  • Gilead Sciences made up 0.07% of Roman Butler Fullerton & Co's portfolio in Q2 2026, its #236 holding.
  • Roman Butler Fullerton & Co first reported a position in Gilead Sciences in Q4 2018 and has held it in 29 quarters since.
  • Roman Butler Fullerton & Co's Gilead Sciences position peaked at $759K in Q4 2018.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Roman Butler Fullerton & Co's 13F filing for Q2 2026, filed 6 Aug 2026.